2011
DOI: 10.1016/j.antiviral.2011.02.008
|View full text |Cite
|
Sign up to set email alerts
|

Emodin inhibits current through SARS-associated coronavirus 3a protein

Abstract: The open-reading-frame 3a of SARS coronavirus (SARS-CoV) had been demonstrated previously to form a cation-selective channel that may become expressed in the infected cell and is then involved in virus release. Drugs that inhibit the ion channel formed by the 3a protein can be expected to inhibit virus release, and would be a source for the development of novel therapeutic agents. Here we demonstrate that emodin can inhibit the 3a ion channel of coronavirus SARS-CoV and HCoV-OC43 as well as virus release from … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
152
1
3

Year Published

2013
2013
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 170 publications
(160 citation statements)
references
References 21 publications
4
152
1
3
Order By: Relevance
“…The typical characteristic of ion channels is the selectivity for one type of ions [42] and this may involve in its viral life cycle regulation [43]. Considering the essential role of viroporins in the viral life cycle, channel inhibitors have become attractive drugs for an antiviral therapy [44][45][46][47][48]. Since the ORF4a channel showed the similar selectivity for monovalent cations to viroporins above, the inhibitors of these viroporins could have the capacity to block ORF4a channel, which should be further investigated.…”
Section: Discussionmentioning
confidence: 99%
“…The typical characteristic of ion channels is the selectivity for one type of ions [42] and this may involve in its viral life cycle regulation [43]. Considering the essential role of viroporins in the viral life cycle, channel inhibitors have become attractive drugs for an antiviral therapy [44][45][46][47][48]. Since the ORF4a channel showed the similar selectivity for monovalent cations to viroporins above, the inhibitors of these viroporins could have the capacity to block ORF4a channel, which should be further investigated.…”
Section: Discussionmentioning
confidence: 99%
“…It is too soon to say whether all of the mutations relevant to the FECV-to-FIPV transition have been found. Although we do not fully understand how these mutations function in disease, they do suggest potential targets for antiviral drugs, such as protease inhibitors (Kim et al, 2013) or viral ion channel blockers (Schwarz et al, 2011).…”
Section: Mutations In the S Genementioning
confidence: 96%
“…bat coronavirus) forms (Tan et al, 2004). The most recent studies on the ORF 3a protein of SARS coronavirus indicate that it forms a cation-selective channel that is expressed in infected cells and is involved in release of virions (Schwarz et al, 2011). Is it also possible that mutations in FIPV ORF 3c protein inhibit apoptosis of infected macrophages?…”
Section: Mutations In the Orf 3c Accessory Genementioning
confidence: 99%
“…Moreover, the antiviral capacity of emodin against enveloped viruses is due to its affinity for phospholipid membrane and weakeness for hydrophobic interactions between hydrocarbon chains in phospholipid bilayers [13,19]. Emodin can also inhibit the 3a ion channel of coronavirus SARS-CoV and HCoV-OC43 as well as virus release from HCoV-OC43 with a K 1/2 value of about 20 μM [16]. And emodin may exert its antiviral activity by direct inhibiting UL12 alkaline nuclease activity of HSV-1 [14,28].…”
Section: Discussionmentioning
confidence: 99%
“…A number of pharmacological properties including anti-microbial, anti-inflammatory, antiviral, anticancer, immunosuppressive, and chemopreventive effects have been suggested [12,13]. Moreover, an increasing number of studies, including those from our laboratory, have extended the antiviral activity of emodin to many RNA and DNA viruses, enveloped and non-enveloped viruses, and pH-dependent and independent viruses, such as herpes simplex virus [14], hepatitis B virus [15], severe acute respiratory syndrome (SARS) coronavirus [16], etc. These findings are crucial for the understanding of the pharmacological properties of emodin, since despite extensive studies of its antiviral effects, the antiviral activity of emodin against CVB 4 virus infections is still incompletely understood.…”
Section: Introductionmentioning
confidence: 99%